AN EXPERIMENTALLY DESIGNED HIGH DOSE SIMULTANEOUS COMBINATION OF A DIAMINOPYRIMIDINE AND FOLINIC ACID FOR THE TREATMENT OF HUMAN MALIGNANCIESPRICE LA; HILL BT.1981; EUR. J. CANCER CLIN. ONCOL.; GBR; DA. 1981; VOL. 17; NO 8; PP. 857-861; BIBL. 23 REF.Article

KINETICS OF METOPRINE, A LIPID-SOLUBLE ANTIFOLATEJONES BR; GORDON CS; UMANS J et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 12; NO 5; PP. 675-680; BIBL. 17 REF.Article

DDMP (2,4-DIAMINO-5-(3',4'-DICHLOROPHENYL)-METHYLPYRIMIDINE)HILL BT; PRICE LA.1980; CANCER TREATM. REV.; GBR; DA. 1980; VOL. 7; NO 2; PP. 95-112; BIBL. 61 REF.Article

DEOXYURIDINE INCORPORATION AS A USEFUL MEASURE OF METHOTREXATE AND METOPRINE UPTAKE AND METABOLIC EFFECTIVENESSSEDWICK WD; FYFE MJ; BROWN OE et al.1979; MOLEC. PHARMACOL.; USA; DA. 1979; VOL. 16; NO 2; PP. 607-613; BIBL. 18 REF.Article

DDMP AND SELECTIVE FOLINIC ACID PROTECTION IN TRE TREATMENT OF MALIGNANT DISEASE: A FURTHER REPORT.PRICE LA; HILL BT; GOLDIE JH et al.1977; CLIN. ONCOL.; G.B.; DA. 1977; VOL. 3; NO 3; PP. 281-286; BIBL. 1 P.Article

LETHAL AND KINETIC EFFECTS OF DDMP (2,4-DIAMINO-5-(3',4'-DICHLOROPHENYL)-6-METHYLPYRIMIDINEHILL BT; WHELAN RDH.1980; EUROP. J. CANCER; GBR; DA. 1980; VOL. 16; NO 1; PP. 147-157; BIBL. 38 REF.Article

AN ENZYME INHIBITION ASSAY 2,4-DIAMINO-5-(3'4'-DICHLOROPHENYL)-6-METHYLPYRIMIDINE (DDMP, NSC 19494).CALVERT AH; CRIDLAND JS; HARRAP KR et al.1977; J. CLIN. PATHOL.; G.B.; DA. 1977; VOL. 30; NO 12; PP. 1154-1157; BIBL. 14 REF.Article

EXPERIMENTAL CHEMOTHERAPY WITH 5-ARYLPYRIMIDINE ANTIFOLATES: PRELIMINARY STUDIES OF TOXICITY AND RESPONSIVENESS OF SARCOMA 180 TO DDMP (NSC-19494) AND DDMP WITH CITROVORUM FACTOR (NSC-3590)SIROTNAK FM; DORICK DM; MOCCIO DM et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 5; PP. 547-553; BIBL. 25 REF.Article

RENAL CELL CARCINOMA: A PRELIMINARY CLINICAL TRIAL OF METHODICHLOROPHEN (D.D.M.P.)HINDMARSH JR; HALL RR; KULATILAKE AE et al.1979; CLIN. ONCOL.; GBR; DA. 1979; VOL. 5; NO 1; PP. 11-15; BIBL. 11 REF.Article

PHASE II EVALUATION OF METOPRINE IN PATIENTS WITH ADVANCED COLORECTAL CARCINOMALYNCH G; KEMENY N; CURRIE V et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 1-2; PP. 127-128; BIBL. 6 REF.Article

PHASE II EVALUATION OF METOPRINE WITH LEUCOVORIN RESCUE IN PATIENTS WITH ADVANCED COLORECTAL CARCINOMALYNCH G; CURRIE V; KEMENY N et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 3; PP. 281-283; BIBL. 7 REF.Article

THE INTRACELLULAR MECHANISM OF ACTION OF METOPRINE (DDMP)BROWMAN GP; CALVERT AH; TAYLOR GA et al.1980; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1980; VOL. 16; NO 12; PP. 1547-1554; BIBL. 32 REF.Article

UNPREDICTABLE HEMATOLOGIC TOXICITY OF WEEKLY DDMP.HANSEN M; LAU ME; HANSEN HH et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 5; PP. 849-850; BIBL. 5 REF.Article

EXPERIMENTAL CHEMOTHERAPY WITH 5-ARYLPYRIMIDINE ANTIFOLATES. FURTHER STUDIES ON TOXICITY AND THE RESPONSIVENESS OF ASCITIC, SOLID, AND INTRACRANIAL SARCOMA 180 TO DDMP AND DDMP WITH CITROVORUM FACTOR.SIROTNAK FM; MOCCIO DM; DORICK DM et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 7; PP. 1325-1332; BIBL. 24 REF.Article

THE DIFFERENCE BETWEEN "SELECTIVE FOLINIC ACID PROTECTION" AND "FOLINIC ACID RESCUE" IN L5178Y CELLS CULTURE.HILL BT; PRICE LA; HARRISON SI et al.1977; EUROP. J. CANCER; G.B.; DA. 1977; VOL. 13; NO 8; PP. 861-871; BIBL. 2 P.Article

Is histamine an anticonvulsive inhibitory transmitter?TUOMISTO, L; TACKE, U.Neuropharmacology. 1986, Vol 25, Num 8, pp 955-958, issn 0028-3908Article

Phase II evaluation of metoprine in advanced pancreatic adenocarcinoma = Essai phase II de la métoprine dans les adénocarcinomes pancréatiques avancésSTERNBERG, C. N; MAGILL, G. B; SORDILLO, P. P et al.Cancer treatment reports. 1984, Vol 68, Num 7-8, pp 1053-1054, issn 0361-5960Article

Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N¹⁰-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprineGALIVAN, J; NIMEC, Z; RHEE, M et al.Cancer research (Baltimore). 1987, Vol 47, Num 20, pp 5256-5260, issn 0008-5472Article